CHTR vs IRD · P/E 11, rev $55.09B vs rev $11.0M
Charter Communications Inc (CHTR) versus Opus Genetics, Inc. (IRD) — a side-by-side from cached financials, not a winner call.
Charter Communications Inc (CHTR) is a telecom services company listed on US.
Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.
Latest reported CHTR revenue for 2024-12-31 was $55.09B. Net income was $5.85B. Revenue was up 0.9% from 2023-12-31 to 2024-12-31. CHTR currently screens at market cap $56.24B and trailing P/E 11.5.
Latest reported IRD revenue for 2024-12-31 was $11.0M. Net income was -$57.5M. Revenue was down 42.3% from 2023-12-31 to 2024-12-31. IRD currently screens at market cap $35.7M.
CHTR currently screens at market cap $56.24B and trailing P/E 11.5. IRD currently screens at market cap $35.7M.
Not investment advice. Open the CHTR and IRD stock pages for the full models.
Not investment advice.